Celeste Porsbjerg

8.7k total citations · 3 hit papers
207 papers, 3.8k citations indexed

About

Celeste Porsbjerg is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Celeste Porsbjerg has authored 207 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Physiology, 124 papers in Pulmonary and Respiratory Medicine and 40 papers in Immunology and Allergy. Recurrent topics in Celeste Porsbjerg's work include Asthma and respiratory diseases (171 papers), Respiratory and Cough-Related Research (82 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (52 papers). Celeste Porsbjerg is often cited by papers focused on Asthma and respiratory diseases (171 papers), Respiratory and Cough-Related Research (82 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (52 papers). Celeste Porsbjerg collaborates with scholars based in Denmark, United Kingdom and Sweden. Celeste Porsbjerg's co-authors include Vibeke Backer, Asger Sverrild, Andrew Menzies‐Gow, Anna von Bülow, Lauri Lehtimäki, Dominick Shaw, Erik Melén, Charlotte Suppli Ulrik, Simon Francis Thomsen and John D. Brannan and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Celeste Porsbjerg

192 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asthma

2023 275 citations Celeste Porsbjerg et al. profile →
Airway hyperresponsiveness in asthma: The role of the epithelium

2024 49 citations Peter Bradding, Celeste Porsbjerg et al. Journal of Allergy and Clinical Immunology profile →
The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma

2024 45 citations Richard Russell, Louis‐Philippe Boulet et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Celeste Porsbjerg

Since Specialization

Citations

This map shows the geographic impact of Celeste Porsbjerg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celeste Porsbjerg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celeste Porsbjerg more than expected).

Fields of papers citing papers by Celeste Porsbjerg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celeste Porsbjerg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celeste Porsbjerg. The network helps show where Celeste Porsbjerg may publish in the future.

Co-authorship network of co-authors of Celeste Porsbjerg

This figure shows the co-authorship network connecting the top 25 collaborators of Celeste Porsbjerg. A scholar is included among the top collaborators of Celeste Porsbjerg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celeste Porsbjerg. Celeste Porsbjerg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of dupilumab on mucus burden in patients with moderate-to-severe asthma: the VESTIGE trial 2025 ·American Journal of Respiratory and Critical Care Medicine ·Celeste Porsbjerg, Eleanor M. Dunican, Njira Lugogo, Mario Castro, Alberto Papi, Vibeke Backer, Christopher E. Brightling, (unknown), J. Christian Virchow, Mei Zhang, Xavier Soler, Paul J. Rowe, Yamo Deniz, (unknown), Harry Sacks, Juby A. Jacob‐Nara	0
2	Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register 2025 ·Respiratory Medicine ·(unknown), Kjell Erik Julius Håkansson, (unknown), (unknown), Johannes Martin Schmid, Sofie Lock Johansson, (unknown), Claus Rikard Johnsen, Anna von Bülow, (unknown), Niels Steen Krogh, Ole Hilberg, (unknown), (unknown), (unknown), Celeste Porsbjerg	3
3	Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthma 2025 ·European Respiratory Journal ·(unknown), (unknown), Susanne Hansen, (unknown), Anna von Bülow, Ole Hilberg, (unknown), Claus Rikard Johnsen, Sofie Lock Johansson, (unknown), Linda Makowska Rasmussen, Johannes Martin Schmid, Charlotte Suppli Ulrik, Celeste Porsbjerg, Kjell Erik Julius Håkansson	6
4	Biologic Prescription Patterns and Biomarker Determinants of First‐Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis 2025 ·Clinical & Experimental Allergy ·(unknown), Kjell Erik Julius Håkansson, Susanne Hansen, (unknown), Johannes Martin Schmid, Sofie Lock Johansson, Linda Makowska Rasmussen, (unknown), (unknown), Anna von Bülow, Niels Steen Krogh, Ole Hilberg, Simon Francis Thomsen, (unknown), Celeste Porsbjerg	0
5	The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma 2025 ·Journal of Asthma ·Kjell Erik Julius Håkansson, Rikke Ibsen, (unknown), (unknown), (unknown), (unknown), Anna von Bülow, Ole Hilberg, Anders Løkke, (unknown), Claus Rikard Johnsen, Sofie Lock Johansson, (unknown), (unknown), (unknown), (unknown), Johannes Martin Schmid, Charlotte Suppli Ulrik, Celeste Porsbjerg	2
6	The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma breakdown → 2024 ·European Respiratory Journal ·Richard Russell, Louis‐Philippe Boulet, Christopher E. Brightling, Ian Pavord, Celeste Porsbjerg, (unknown), Asger Sverrild	45
7	Airway hyperresponsiveness in asthma: The role of the epithelium breakdown → 2024 ·Journal of Allergy and Clinical Immunology ·Peter Bradding, Celeste Porsbjerg, Andréanne Côté, Sven‐Erik Dahlén, Teal S. Hallstrand, Christopher E. Brightling	49
8	Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial 2024 ·Nature Aging ·(unknown), Michael Ben Ezra, Indra Heckenbach, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dayle Sampson, Ryan W. Dellinger, Asger Sverrild, Jonas T. Treebak, Sisse B. Ditlev, Celeste Porsbjerg, Morten Scheibye‐Knudsen	11
9	Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma 2023 ·NEJM Evidence ·Lars H. Nordenmark, Åsa Hellqvist, Claire Emson, Sarah Diver, Celeste Porsbjerg, Janet M. Griffiths, John D. Newell, S. Peterson, (unknown), Jane R. Parnes, Ayman Megally, Gene Colice, Christopher E. Brightling	53
10	Long-term health care resource and cost savings with allergy immunotherapy: REACT study results 2023 ·SHILAP Revista de lepidopterología ·Benedikt Fritzsching, Celeste Porsbjerg, Marco Contoli, Sarah Buchs, Julie Rask Larsen, Nick Freemantle	0
11	Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation 2023 ·Journal of Allergy and Clinical Immunology ·(unknown), (unknown), Morten Hvidtfeldt, (unknown), Anna von Bülow, Ditte Kjærsgaard Klein, Lena Uller, Jonas S. Erjefält, Celeste Porsbjerg, Asger Sverrild	18
12	Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study 2023 ·Journal of Allergy and Clinical Immunology ·Marco Contoli, Celeste Porsbjerg, Sarah Buchs, Julie Rask Larsen, Nick Freemantle, Benedikt Fritzsching	15
13	Tezepelumab decreases airway epithelial IL‐33 and T2‐inflammation in response to viral stimulation in patients with asthma 2023 ·Allergy ·Asger Sverrild, (unknown), Juan José Nieto‐Fontarigo, Sangeetha Ramu, Morten Hvidtfeldt, Mandy Menzel, Jennifer Kearley, Janet M. Griffiths, J R Parnes, Celeste Porsbjerg, Lena Uller	19
14	Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial 2023 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Sangeetha Ramu, Asger Sverrild, Juan José Nieto‐Fontarigo, (unknown), Samuel Cerps, (unknown), (unknown), (unknown), (unknown), Mandy Menzel, Ditte Kjærsgaard Klein, Susanne Hansen, Lena Uller, Celeste Porsbjerg	35
15	House dust mite sensitization and exposure affects bronchial epithelial anti‐microbial response to viral stimuli in patients with asthma 2022 ·Allergy ·Samuel Cerps, Asger Sverrild, Sangeetha Ramu, Juan José Nieto‐Fontarigo, Hamid Akbarshahi, Mandy Menzel, Cecilia Andersson, (unknown), Morten Hvidtfeldt, Celeste Porsbjerg, Lena Uller	14
16	Treating severe asthma: Targeting the IL‐5 pathway 2021 ·Clinical & Experimental Allergy ·(unknown), Celeste Porsbjerg, Sisse B. Ditlev, Ditte Kjærsgaard Klein, Korneliusz Golebski, (unknown), (unknown), Job J.M.H. van Bragt, (unknown), Sven‐Erik Dahlén, Christopher E. Brightling, Susanne J. H. Vijverberg, Anke H. Maitland‐van der Zee	47
17	Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients 2021 ·ERJ Open Research ·Stine Johnsen, Stefan M. Sattler, Kamilla Woznica Miskowiak, (unknown), (unknown), Lars Pedersen, Helle Frost Andreassen, (unknown), (unknown), Michael Brun Andersen, Lisbeth Marner, (unknown), Henrik Hansen, Sisse B. Ditlev, Celeste Porsbjerg, Thérèse Lapperre	51
18	SHARP: enabling generation of real-world evidence on a pan-European scale to improve the lives of individuals with severe asthma 2021 ·ERJ Open Research ·Job J.M.H. van Bragt, Susanne Hansen, Ratko Djukanović, Elisabeth H. Bel, Anneke Ten Brinke, Scott Wagers, Anke H. Maitland‐van der Zee, Celeste Porsbjerg	9
19	Biomarker‐guided management reduces exacerbations in non‐eosinophilic asthma in pregnancy: A secondary analysis of a randomized controlled trial 2019 ·Respirology ·Vanessa E. Murphy, Celeste Porsbjerg, Annelies L. Robijn, Peter G. Gibson	13
20	IL ‐33 is related to innate immune activation and sensitization to HDM in mild steroid‐free asthma 2016 ·Clinical & Experimental Allergy ·Celeste Porsbjerg, Katherine J. Baines, Peter G. Gibson, Anna Bergqvist, Jonas S. Erjefält, Asger Sverrild, Vibeke Backer	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact